These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 20801597)

  • 1. Qualitative and quantitative studies on human B7.1-Fc fusion protein and the application in pharmacokinetic study in rhesus monkeys.
    Chen Z; Liu R; Che J; Shi H; Hou Y; Liu Y; Sun L; Tan L; Shan C; Hu P; Cheng Y
    J Pharm Biomed Anal; 2011 Jan; 54(1):133-40. PubMed ID: 20801597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an immunoassay for human-specific quantitation of therapeutic antibodies in serum samples from non-human primates.
    Stubenrauch K; Wessels U; Lenz H
    J Pharm Biomed Anal; 2009 May; 49(4):1003-8. PubMed ID: 19250787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.
    Suzuki T; Ishii-Watabe A; Tada M; Kobayashi T; Kanayasu-Toyoda T; Kawanishi T; Yamaguchi T
    J Immunol; 2010 Feb; 184(4):1968-76. PubMed ID: 20083659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A universal surrogate peptide to enable LC-MS/MS bioanalysis of a diversity of human monoclonal antibody and human Fc-fusion protein drug candidates in pre-clinical animal studies.
    Furlong MT; Ouyang Z; Wu S; Tamura J; Olah T; Tymiak A; Jemal M
    Biomed Chromatogr; 2012 Aug; 26(8):1024-32. PubMed ID: 22623136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
    Liu A; Hu P; Khawli LA; Epstein AL
    Clin Cancer Res; 2005 Dec; 11(23):8492-502. PubMed ID: 16322313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-Fc fusion therapeutics, traps, and MIMETIBODY technology.
    Huang C
    Curr Opin Biotechnol; 2009 Dec; 20(6):692-9. PubMed ID: 19889530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7.1/NHS76: a new costimulator fusion protein for the immunotherapy of solid tumors.
    Liu A; Hu P; Khawli LA; Epstein AL
    J Immunother; 2006; 29(4):425-35. PubMed ID: 16799338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity.
    Chakrabarti R; Zhou ZF; Chang Y; Prud'homme GJ
    Vaccine; 2005 Aug; 23(37):4553-64. PubMed ID: 15919138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
    Stubenrauch K; Wessels U; Essig U; Vogel R; Schleypen J
    J Pharm Biomed Anal; 2010 Jun; 52(2):249-54. PubMed ID: 20083366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties.
    Wozniak-Knopp G; Bartl S; Bauer A; Mostageer M; Woisetschläger M; Antes B; Ettl K; Kainer M; Weberhofer G; Wiederkum S; Himmler G; Mudde GC; Rüker F
    Protein Eng Des Sel; 2010 Apr; 23(4):289-97. PubMed ID: 20150180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
    Galea-Lauri J; Darling D; Gan SU; Krivochtchapov L; Kuiper M; Gäken J; Souberbielle B; Farzaneh F
    J Immunol; 1999 Jul; 163(1):62-70. PubMed ID: 10384100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New highly sensitive enzyme immunoassay for the determination of pravastatin in human plasma.
    Darwish IA; Al-Obaid AR; Al-Malaq HA
    Talanta; 2009 Oct; 79(5):1478-83. PubMed ID: 19635387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of human leukocyte-specific monoclonal antibodies for clinically immunophenotyping lymphocytes of rhesus monkeys.
    Reimann KA; Waite BC; Lee-Parritz DE; Lin W; Uchanska-Ziegler B; O'Connell MJ; Letvin NL
    Cytometry; 1994 Sep; 17(1):102-8. PubMed ID: 8001455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells.
    de Boer M; Kasran A; Kwekkeboom J; Walter H; Vandenberghe P; Ceuppens JL
    Eur J Immunol; 1993 Dec; 23(12):3120-5. PubMed ID: 7504989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of an immunoreceptor assay for simulect based on surface plasmon resonance.
    Deckert F; Legay F
    Anal Biochem; 1999 Oct; 274(1):81-9. PubMed ID: 10527499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach for pharmacokinetics of single-dose cetuximab in rhesus monkeys by surface plasmon resonance biosensor.
    Che J; Wang H; Chen Z; Li X; Hou Y; Shan C; Cheng Y
    J Pharm Biomed Anal; 2009 Sep; 50(2):183-8. PubMed ID: 19446977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly sensitive enzyme immunoassay for evaluation of 2'-deoxycytidine plasma level as a prognostic marker for breast cancer chemotherapy.
    Darwish IA; Mahmoud AM; Aboul-Fadl T; Al-Majed AR; Khalil NY
    Anal Chim Acta; 2009 Jan; 632(2):266-71. PubMed ID: 19110103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of CD28-B7.1 and B7.2 functional interaction in resting human T cells: phosphatidylinositol 3-kinase association to CD28 and cytokine production.
    Ghiotto-Ragueneau M; Battifora M; Truneh A; Waterfield MD; Olive D
    Eur J Immunol; 1996 Jan; 26(1):34-41. PubMed ID: 8566081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.